Kathmandu
Cancer Center
Kathmandu
Cancer Center
Before you start any treatment — surgery, chemotherapy, or radiotherapy — having the diagnosis and plan confirmed by an independent tumour board is standard practice globally. It takes 5 days and may change your treatment entirely.
Surgical oncologists operate. Medical oncologists know when chemotherapy or radiotherapy should come first. A tumour board ensures you hear both views before going to theatre.
Immunotherapy eligibility, clinical trial access, and targeted therapy options are not always discussed by every oncologist. A tumour board review ensures all options are on the table.
Distance makes it difficult to ask follow-up questions, challenge a recommendation, or get a second set of eyes on your pathology and imaging. A KCC tumour board review provides an independent Nepal-based assessment.
Rare cancers — sarcomas, unusual lymphomas, uncommon head and neck tumours — are more likely to be misdiagnosed or misstaged. Tumour board review is especially valuable for rare histologies.
When a cancer returns after treatment, the management changes significantly. A tumour board review ensures all second-line options — including immunotherapy — are considered before the next treatment decision.
You cannot always articulate why you are uncertain about a recommendation. That uncertainty is worth investigating before you commit to a major treatment course.
Family members often seek second opinions on behalf of patients who are too overwhelmed to advocate for themselves. KCC's team will engage with family members as full participants in the second opinion process.
The most important fact about cancer second opinions:
Getting a second opinion does not insult your first doctor. It does not damage your relationship with your existing hospital. It does not delay your treatment in any meaningful way. It is a medically recognised, globally encouraged practice. If a doctor actively discourages you from seeking a second opinion — that itself is a reason to seek one.
A multidisciplinary tumour board (MTB), also called an MDT (multidisciplinary team), is a formal structured meeting in which specialists from different oncology disciplines review a cancer patient's case together and reach a consensus recommendation.
It is the global standard of cancer care. The UK's NHS mandates tumour board review for every new cancer case. NCCN guidelines recommend MDT for complex cancers. In Nepal, KCC is one of the few hospitals that operates a formal, regular multidisciplinary tumour board.
When you ask for a second opinion at KCC, your case is placed before this board. You do not get one specialist's view — you get the collective review of every relevant discipline.
Leads chemotherapy and immunotherapy decisions. Reviews biomarker results, drug selection, dose, and sequence. AIIMS / PGI-trained at KCC.
Evaluates operability, surgical approach, margins, and whether surgery-first or chemotherapy-first is appropriate. Critical for breast, bowel, and liver tumour decisions.
Assesses whether radiotherapy has a role — as primary treatment, adjuvant, or palliative. Essential for head and neck, cervical, lung, and oesophageal cases.
Re-reads biopsy slides and histopathology to independently confirm diagnosis, grade, subtype, and biomarker status (PD-L1, HER2, MSI). The most common source of diagnosis change.
Re-reads CT, MRI, and PET imaging to independently confirm staging and extent of disease. Staging errors — overstaging or understaging — directly change surgical and treatment plans.
KCC tumour board second opinion — timeline
You meet the oncologist. Previous reports and imaging are reviewed. Any missing biomarker tests are ordered. Case is formally placed before the tumour board. Duration: 60–90 minutes.
KCC's pathologist re-reads your biopsy slides (bring the unstained slides or tissue block). The radiologist independently reviews your CT / MRI / PET imaging disc. Additional staining or biomarker tests are processed if ordered.
All five specialists review your case together. Discussion covers diagnosis confirmation, staging accuracy, treatment options and sequence, and any missing investigations. Consensus recommendation is reached.
The tumour board's recommendation is documented in writing: confirmed diagnosis and staging, recommended treatment plan, drugs if applicable, and any further tests required. Provided in English. Explanation in Nepali at follow-up appointment.
What the tumour board reviews
KCC City Clinic New Baneshwor brings multidisciplinary cancer consultations and second opinions to the heart of Kathmandu. No 45-minute drive to Tathali. Baneshwor is central, accessible from every corner of the valley, and served by public transport from all major areas. The same KCC oncologists. The same tumour board process.
तपाईंलाई क्यान्सर भएको बताइएको छ — र उपचार सुरु गर्नुभन्दा अगाडि एउटा प्रश्न उठेको छ: के यो निदान ठीक छ? के यही उपचार सही हो?
KCC मा दोस्रो राय लिनुको अर्थ एक मात्र डाक्टरको विचार होइन। बहुविषयक ट्युमर बोर्ड (Tumour Board) — मेडिकल अन्कोलोजिस्ट, सर्जिकल अन्कोलोजिस्ट, रेडिएशन अन्कोलोजिस्ट, पाथोलोजिस्ट, र रेडिओलोजिस्ट — सबै मिलेर तपाईंको case review गर्छन्।
यो सेवा अब बानेश्वर, काठमाडौं मा पनि उपलब्ध छ — काठमाडौं उपत्यकाको केन्द्रमा, सजिलो पहुँचसहित।
A multidisciplinary tumour board (MTB), also called an MDT (multidisciplinary team), is a structured meeting where cancer specialists from different disciplines review a patient's case together — not separately. At KCC Nepal, the tumour board includes a medical oncologist, surgical oncologist, radiation oncologist, pathologist, and diagnostic radiologist.
The board reaches a consensus recommendation on diagnosis, staging, and treatment. The recommendation is documented in writing. This is the global standard of cancer care and is how cancer cases are managed at the world's leading oncology centres — including AIIMS, Tata Memorial, and major European cancer hospitals.
Yes — at KCC Kathmandu. KCC operates a formal, regular multidisciplinary tumour board that reviews all new cancer cases and second opinion requests. The board includes five specialists. KCC is one of the few hospitals in Nepal with a formal MDT process that meets the international standard.
The board is available at both KCC locations: the main Tathali campus and the Baneshwor clinic in central Kathmandu. Second opinion requests are formally presented to the board — you do not simply see one doctor.
KCC offers cancer second opinions at two Kathmandu locations. KCC Baneshwor Clinic is in central Kathmandu — convenient for patients from across the valley, accessible by public transport from Thamel, Patan, Koteshwar, and all major areas. KCC Tathali Campus (main hospital) is in Bhaktapur, 25 minutes from Koteshwar.
No referral is required. WhatsApp 9818-226237 to book a second opinion at either location. Confirm the Baneshwor clinic schedule before visiting.
No. A second opinion at KCC carries no obligation. You receive the tumour board's written recommendation. You are free to take that document to your original hospital, continue treatment there, or return to KCC. Many patients use a KCC second opinion to gain confidence in their existing plan and continue treatment where they started.
KCC's team does not pressure patients to change hospitals. The purpose of the second opinion is to give you the most accurate picture — what you do with it is entirely your decision.
A regular second opinion means seeing one specialist from one discipline — typically the same discipline as your original doctor. If your first oncologist is a medical oncologist, your second opinion is usually another medical oncologist's view. This has value, but is limited.
A tumour board second opinion at KCC means five specialists from five different disciplines reviewing your case simultaneously. The pathologist may find the original biopsy was read as the wrong subtype. The radiologist may find the tumour is smaller than staged. The surgical oncologist may disagree with the recommendation to operate first. These differences are debated at the board meeting — and the consensus recommendation you receive reflects all of those views, not just one.
Yes. KCC reviews cases from AIIMS New Delhi, PGI Chandigarh, Tata Memorial Mumbai, RGCI, Apollo, Medanta, and any other hospital. Second opinions on diagnoses from leading hospitals are not unusual — they are standard practice globally, and even the best hospitals' pathology and staging are occasionally refined upon independent review.
KCC's oncologists were trained at AIIMS and PGI — the same institutions. The clinical framework is identical. Bring all imaging discs, biopsy reports, and treating oncologist letters. Hindi and English reports are read without difficulty.
For most cancer types, a 5–7 day delay to obtain a second opinion does not meaningfully affect outcome. The vast majority of cancers do not progress in a way that changes prognosis within one week. The delay from receiving a wrong or incomplete treatment plan — and then changing course after several cycles — is far longer and more disruptive.
The exception is true oncological emergencies — spinal cord compression, severe airway obstruction, rapidly progressing aggressive lymphoma. KCC's team will advise you if your case is genuinely urgent and the second opinion process needs to be expedited.
A consultation fee applies for the initial appointment. Any additional biomarker tests or imaging ordered during the process are charged at standard KCC rates. The tumour board review itself is part of KCC's clinical process. NHIF may cover part of the consultation for eligible card holders.
WhatsApp 9818-226237 to ask about current consultation fees before your visit. A written cost estimate is always provided before any procedure. Second opinions do not require package purchases — you pay for what is needed.
The KCC Baneshwor clinic is an outpatient consultation clinic in central Kathmandu, specifically designed to remove the friction of travelling to Bhaktapur for patients who need a consultation or second opinion. The same KCC oncologists rotate between Baneshwor and the Tathali main campus — you see the same doctors.
The Baneshwor clinic handles consultations, second opinions, and follow-up appointments. Procedures, infusions, imaging, and inpatient care continue at the main Tathali campus. WhatsApp 9818-226237 to confirm the Baneshwor schedule before your visit.
A question not answered here?
💬 WhatsApp your questionFive specialists. One written recommendation. No obligation to treat at KCC. Available at Baneshwor, central Kathmandu — and at KCC Tathali. WhatsApp your reports today. First appointment within days.
KCC Baneshwor — central Kathmandu · KCC Tathali — Nala Road, Bhaktapur
Sunday–Friday 9am–5pm · No referral required · Consultations in Nepali ·
WhatsApp reports to 9818-226237 — first appointment within days